Affected populations: Acromegaly is estimated to affect approximately 50 to 70 people out of every million. However, the true figure may be higher, as the symptoms develop slowly and thus may go ...

Acromegaly is due to hypersecretion of growth hormone and insulin-like growth factor I (IGF-I). The aim of treatment is to limit this excess secretion and to reduce morbidity and mortality.

Gamma knife radiosurgery (GKR) is used as an adjuvant therapy in patients with acromegaly if primary surgery fails or is contraindicated. Studies that extensively examine the efficacy and safety ...